Case Study

Expanding the cell and gene therapy manufacturing workflow

Expanding the cell and gene therapy manufacturing workflow

“ “ We have barely scratched the surface of what biotech companies can do with these life-changing therapies. Traditional therapies can prevent and treat a number of life-threatening diseases, but we have never truly cured a disease. The cell and gene therapy space offers this opportunity to cure diseases—if we can figure out how to make these therapies accessible to patients more broadly. Expanding the cell and gene therapy manufacturing workflow A collaboration between Northeastern University’s BATL and Thermo Fisher Scientific Cell and gene therapy The challenge To bolster its hands-on education for academics, industry researchers, and regulators, the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University sought to expand its cell and gene therapy off

Join for free to read